Terms: = Head and neck cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2 AND Treatment
19 results:
1. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
[TBL] [Abstract] [Full Text] [Related]
2. CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in head and neck Squamous Cell Carcinoma.
Zeng L; Nikolaev A; Xing C; Della Manna DL; Yang ES
Mol Cancer Ther; 2020 Jun; 19(6):1279-1288. PubMed ID: 32371584
[TBL] [Abstract] [Full Text] [Related]
3. notch2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.
Zou Y; Yang R; Huang ML; Kong YG; Sheng JF; Tao ZZ; Gao L; Chen SM
J Exp Clin Cancer Res; 2019 Nov; 38(1):456. PubMed ID: 31699119
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls cancer Stem-like Features.
Kao SH; Cheng WC; Wang YT; Wu HT; Yeh HY; Chen YJ; Tsai MH; Wu KJ
Cancer Res; 2019 May; 79(10):2549-2563. PubMed ID: 30877109
[TBL] [Abstract] [Full Text] [Related]
5. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
Xie M; Wei S; Wu X; Li X; You Y; He C
Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
[TBL] [Abstract] [Full Text] [Related]
6. Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma.
Zou Y; Fang F; Ding YJ; Dai MY; Yi X; Chen C; Tao ZZ; Chen SM
Mol Med Rep; 2016 Oct; 14(4):3517-24. PubMed ID: 27572051
[TBL] [Abstract] [Full Text] [Related]
7. notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.
Qu J; Song M; Xie J; Huang XY; Hu XM; Gan RH; Zhao Y; Lin LS; Chen J; Lin X; Zheng DL; Lu YG
Mol Cell Biochem; 2016 Jan; 411(1-2):135-41. PubMed ID: 26427670
[TBL] [Abstract] [Full Text] [Related]
8. Therapy of advanced squamous cell carcinoma of the skin.
Bejar C; Maubec E
Curr Treat Options Oncol; 2014 Jun; 15(2):302-20. PubMed ID: 24643778
[TBL] [Abstract] [Full Text] [Related]
9. Refractory nasopharyngeal carcinoma: positron emission tomography combined with computed tomography-guided 125I seed implantation therapy after repeated traditional radiochemotherapy.
Zhang F; Wu K; Gao F; Zhang W; Shi F; Li C
Otolaryngol Head Neck Surg; 2013 Sep; 149(3):417-23. PubMed ID: 23715683
[TBL] [Abstract] [Full Text] [Related]
10. Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy.
Egloff AM; Grandis JR
Clin Cancer Res; 2012 Oct; 18(19):5188-95. PubMed ID: 22773520
[TBL] [Abstract] [Full Text] [Related]
11. Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
Chen SM; Liu JP; Zhou JX; Chen C; Deng YQ; Wang Y; Tao ZZ
Cancer Lett; 2011 Jul; 306(1):76-84. PubMed ID: 21420785
[TBL] [Abstract] [Full Text] [Related]
12. Resveratrol induces notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
[TBL] [Abstract] [Full Text] [Related]
13. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
[TBL] [Abstract] [Full Text] [Related]
14. Upregulation of Notch pathway molecules in oral squamous cell carcinoma.
Hijioka H; Setoguchi T; Miyawaki A; Gao H; Ishida T; Komiya S; Nakamura N
Int J Oncol; 2010 Apr; 36(4):817-22. PubMed ID: 20198324
[TBL] [Abstract] [Full Text] [Related]
15. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG hn2 randomized trial of an antimicrobial lozenge to prevent mucositis.
Duncan GG; Epstein JB; Tu D; El Sayed S; Bezjak A; Ottaway J; Pater J;
Head Neck; 2005 May; 27(5):421-8. PubMed ID: 15782422
[TBL] [Abstract] [Full Text] [Related]
16. Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies.
Frei E; Holden SA; Gonin R; Waxman DJ; Teicher BA
Cancer Chemother Pharmacol; 1993; 33(2):113-22. PubMed ID: 8261570
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of tumour associated antigen expressed on human squamous cell carcinoma cell lines by recombinant interferon-alpha.
Maniar HS; Desai SA; Chiplunkar SV; Amin MK; Rao RS; Gangal SG
Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):57-61. PubMed ID: 8180578
[TBL] [Abstract] [Full Text] [Related]
18. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
[TBL] [Abstract] [Full Text] [Related]
19. Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer.
Israel L; Aguilera J; Soudant J; Penot JC; Breau JL; Morere JF
Am J Clin Oncol; 1983 Jun; 6(3):305-11. PubMed ID: 6189388
[TBL] [Abstract] [Full Text] [Related]
